ImmuCell Corporation (FRA:IUL)

ImmuCell Revenue

ImmuCell had revenue of $5.51M USD in the quarter ending September 30, 2025, a decrease of -8.41%. This brings the company's revenue in the last twelve months to $27.77M, up 16.49% year-over-year. In the year 2024, ImmuCell had annual revenue of $26.49M with 51.64% growth.

• Revenue (ttm): $27.77M
• Revenue Growth: +16.49%
• P/S Ratio: 2.13
• Revenue / Employee: $370.26K
• Employees: 75
• Market Cap: 50.51M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	26.49M	9.02M	51.64%
Dec 31, 2023	17.47M	-1.10M	-5.90%
Dec 31, 2022	18.57M	-675.01K	-3.51%
Dec 31, 2021	19.24M	3.90M	25.43%
Dec 31, 2020	15.34M	1.62M	11.80%
Dec 31, 2019	13.72M	2.74M	24.91%
Dec 31, 2018	10.99M	555.21K	5.32%
Dec 31, 2017	10.43M	887.13K	9.30%
Dec 31, 2016	9.54M	-684.73K	-6.69%
Dec 31, 2015	10.23M	2.63M	34.64%
Dec 31, 2014	7.60M	1.59M	26.46%
Dec 31, 2013	6.01M	617.24K	11.45%
Dec 31, 2012	5.39M	278.79K	5.45%
Dec 31, 2011	5.11M	724.95K	16.53%
Dec 31, 2010	4.39M	-119.56K	-2.65%
Dec 31, 2009	4.51M	-122.55K	-2.65%
Dec 31, 2008	4.63M	-6.21M	-57.31%
Dec 31, 2007	10.84M	1.73M	19.04%
Dec 31, 2006	9.11M	-109.26K	-1.19%
Dec 31, 2005	9.22M	-	-